Drugs / Licensed Influenza Vaccine 2
Trials 0
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06821061 Comparator | Feb → Dec 2025 | COVID-19, influenza | BioNTech SE | Completed | No outcome recorded |
| Phase 1/2 | NCT06683352 Comparator | Nov 2024 → Jul 2025 | COVID-19, influenza | BioNTech SE | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Licensed Influenza Vaccine 2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06821061 ↗ |
| Modality | Vaccine | “Licensed Influenza Vaccine 2” NCT06683352 ↗ |